insights_auto
Outlook: 61.5% bullish·15.4% bearish
Go to analysischevron_right
SYRE:NASDAQ
Spyre Therapeutics Inc
92,72 $
arrow_downward
-0,50%(-0,47) 1D
89,00 $
arrow_downward
-4,01% (-3,72)bedtimeAfter hours
Closed: 5 հոկ, 16:00:00 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SYRE...
Open
93,02 $
High
95,01 $
Low
89,49 $
Mkt. cap
8,18 մլրդ
Avg. vol.
1,32 մլն
Volume
642,76 հզր
52-wk high
110,18 $
52-wk low
15,90 $
EPS
-2,32 $
Beta
3,10
Shares outstanding
88,17 մլն
No. of employees
125
Open
93,02 $
High
95,01 $
Low
89,49 $
Mkt. cap
8,18 մլրդ
Avg. vol.
1,32 մլն
Volume
642,76 հզր
52-wk high
110,18 $
52-wk low
15,90 $
EPS
-2,32 $
Beta
3,10
Shares outstanding
88,17 մլն
No. of employees
125
News stories
From web sources and news partners
Yahoo Finance
·
52 րոպե առաջ
Spyre Therapeutics stock falls on public offering launch
Dealroom
·
1 ժամ առաջ
Spyre launches stock sale to fund new SPY072 late-stage program
scanx.trade
·
1 ժամ առաջ
Spyre Therapeutics launches underwritten public offering of common stock
Investing.com UK
·
1 ժամ առաջ
Spyre Therapeutics launches public stock offering By Investing.com
About Spyre Therapeutics Inc
CEO-
Employees125
Founded01 հնվ, 2013 թ.
HeadquartersՈւոլթեմ, Մասսաչուսեթս, Միացյալ Նահանգներ
Sector-
Websitespyre.com